Similar articles

• An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia.

  McAnulty JM, Jauncey ME, Monger CK, Hailstone ST, Alam NK, Mannes TF, Capon AG, Irvine K, Armstrong PK, Kaldor JM. McAnulty JM, et al. Drug Alcohol Rev. 2007 May;26(3):321-31. doi: 10.1080/09595230701247798. Drug Alcohol Rev. 2007. PMID: 17454022
• [Life-threatening, recurrent arrhythmia in patients on high-dose methadone treatment: torsade de pointes].

  Al-Shakarshi JS, Bent-Hansen L, Jensen GB. Al-Shakarshi JS, et al. Ugeskr Laeger. 2004 Aug 30;166(36):3104-5. Ugeskr Laeger. 2004. PMID: 15387312 Danish. No abstract available.
• [Interactions with methadone and buprenorphine].

  Bakke E, Bachs L. Bakke E, et al. Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2364-6. doi: 10.4045/tidsskr.09.0471. Tidsskr Nor Laegeforen. 2009. PMID: 19935937 Norwegian.
• [Treatment of skin changes after extravenous administration of adriamycin].

  Koralewski P. Koralewski P. Wiad Lek. 1987 Dec 15;40(24):1689-92. Wiad Lek. 1987. PMID: 2967588 Review. Polish. No abstract available.
• [Opiate replacement therapy in France: assessment of the public policies].

  Chast F. Chast F. Ann Pharm Fr. 2009 Sep;67(5):299-303. doi: 10.1016/j.pharma.2009.06.006. Epub 2009 Jul 30. Ann Pharm Fr. 2009. PMID: 19695365 Review. French. No abstract available.